Press Release: February 23, 2016

PRESS RELEASE

Contact:

Paul Anderson

WCT, Inc. CEO

952-937-2804

panderson@dermaclose.com

FOR IMMEDIATE RELEASE

WCT, INC. ANNOUNCES DERMACLOSE HAS BEEN USED IN OVER 15,000 CASES

Eden Prairie, MN February 23, 2016 – Wound Care Technologies, Inc. is pleased to announce that the DermaClose Continuous External Tissue Expander has now been used in over 15,000 cases to date!  The DermaClose device is used by plastic surgeons, orthopedic surgeons, general surgeons and others on wounds such as fasciotomies, excisional wounds, flap donor sites, sternal wounds, knee wounds, necrotizing fasciitis and trauma wounds.

There are now 42 case reports on DermaClose and more coming in almost every month. Over 20 clinical papers support the efficacy and cost effectiveness of the use of DermaClose for wounds with large skin deficits or where high tension makes wound closure difficult. A growing number of physicians are using DermaClose for offloading to prevent wound dehiscence.

Wound Care Technologies, Inc. is a Minnesota based company which developed and is marketing the DermaClose, The DermaClose is a very effective alternative to skin grafts and other treatment modalities such as negative pressure wound therapy. The DermaClose can save significant money by reducing length of hospital stay compared to other treatment methods. The WCT team is proud to be able to assist surgeons in helping their patients achieve better outcomes and get them out of the hospital faster resulting in overall reduced costs to our healthcare system.

###